M6ARNA修饰:专注于非小细胞肺癌的进展,治疗策略和挑战
Yuyang Yan1, Jiarui Yin1, Quan Ding1
1School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Frontiers in oncology
|July 31, 2025
概括
在非小细胞肺癌 (NSCLC) 的发展和进展中,N6-甲基氨酸 (m6A) RNA 修饰至关重要. 针对m6A提供了新的诊断,预后和克服NSCLC治疗耐药性的潜力.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- N6-甲基氨酸 (m6A) 是RNA的一个关键表观遗传调节剂.
- m6A修饰在肺癌 (LC) 的生物学中发挥着重要作用.
研究的目的:
- 在非小细胞肺癌 (NSCLC) 中审查m6A的调节网络.
- 阐明m6A在瘤进展,新陈代谢,血管生成和瘤微环境中的作用.
- 探索m6A作为NSCLC中的生物标志物和治疗点的潜力.
主要方法:
- 关于NSCLC中m6A的当前研究的文献综述.
- 对m6A对各种癌症特征的影响的综合发现.
- 分析m6A在非编码RNA修饰和治疗耐药性的作用.
主要成果:
- m6A影响NSCLC的扩散,亡,入侵和转移.
- m6A调节新陈代谢重编程 (糖溶解,铁),血管新生和TME.
- 非编码RNA的m6A修饰有助于LC恶性瘤和治疗耐药性.
结论:
- m6A是NSCLC的一个有前途的生物标志物和治疗点.
- 临床翻译面临诸多挑战,包括检测标准化和网络复杂性.
- 未来需要进行多学科研究,以推进精密瘤学的m6A调制.
相关概念视频
RNA Stability
33.9K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
RNA Editing
9.2K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.2K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Nuclear Export of mRNA
7.9K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.9K


